Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2

Muscle and Nerve

Volumn 38, Issue 5, 2008, Pages 1405-1411

  Pisani, Valerio ^a   Panico, Maria Beatrice ^a   Terracciano, Chiara ^a   Bonifazi, Emanuela ^a   Meola, Giovanni ^b   Novelli, Giuseppe ^a   Bernardi, Giorgio ^a   Angelini, Corrado ^c   Massa, Roberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Central nuclei; DM1; DM2; Muscle biopsy; Myotonic dystrophy

Indexed keywords

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE HYPERTROPHY; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 2; PHENOTYPE; PREDICTIVE VALIDITY; PREVALENCE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; BIOPSY; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MYOSIN HEAVY CHAINS; MYOTONIC DYSTROPHY;

EID: 55749099951     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21122     Document Type: Article

References (19)

1. Bonifazi E, Vallo L, Giardina E, Botta A, Novelli G. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2. Diagn Mol Pathol 2004;13:164-166.
2. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
3. Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron. Neurology 1969;19:378-393.
4. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-664.
5. Furling D, Lam le T, Agbulut O, Butler-Browne GS, Morris GE. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am J Pathol 2003;162:1001-1009.
6. Johnson MA, Polgar J, Weightman D, Appleton D. Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci 1973;18:111-129.
7. Kimura T, Nakamori M, Lueck JD, Pouliquin P, Aoike F, Fujimura H, et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 2005;14:2189-2200.
8. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867.
9. Merlini L, Sabatelli P, Columbaro M, Bonifazi E, Pisani V, Massa R, et al. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Muscle Nerve 2005;31:764-767.
10. Moore GE, Roses AD, Pericak-Vance MA, Garrett WE Jr, Schachat FH. Promiscuous expression of myosin in myotonic dystrophy. Muscle Nerve 1986;9:355-363.
11. Nonaka I, Satoyoshi E. Myotonic disorders. In: Mastaglia FL, Walton J, editors. Skeletal muscle pathology. Edinburgh: Churchill Livingstone; 1992. p 319-342.
12. Ranum LPW, Cooper TA. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 2006;29:259-277.
13. Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Speich N, Reiners K, et al. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52:25-31.
14. Salehi LB, Bonifazi E, Stasio ED, Gennarelli M, Botta A, Vallo L, et al. Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients. Genet Test 2007;11:84-90.
15. Sallinen R, Vihola A, Bachinski LL, Huoponen K, Haapasalo H, Hackman P, et al. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul Disord 2004;14:274-283.
16. Schoser BG, Schneider-Gold C, Kress W, Goebel HH, Reilich P, Koch MC, et al. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 2004;29:275-281.
17. Thornton CA, Griggs RC, Moxley RT 3rd. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994;35:269-272.
18. Tohgi H, Kawamorita A, Utsugisawa K, Yamagata M, Sano M. Muscle histopathology in myotonic dystrophy in relation to age and muscular weakness. Muscle Nerve 1994;17:1037-1043.
19. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003;60:1854-1857.